|
MON2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.638300E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.584400E-04 |
| Normal-vs-Stage2 |
8.822000E-03 |
| Normal-vs-Stage3 |
6.024200E-03 |
| Normal-vs-Stage4 |
8.204900E-03 |
| Stage1-vs-Stage2 |
7.227400E-01 |
| Stage1-vs-Stage3 |
7.886600E-01 |
| Stage1-vs-Stage4 |
6.702400E-01 |
| Stage2-vs-Stage3 |
9.110000E-01 |
| Stage2-vs-Stage4 |
8.727200E-01 |
| Stage3-vs-Stage4 |
8.019000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.401100E-04 |
| Normal-vs-AfricanAmerican |
1.495640E-02 |
| Normal-vs-Asian |
3.613600E-01 |
| Caucasian-vs-AfricanAmerican |
6.145400E-01 |
| Caucasian-vs-Asian |
8.875000E-01 |
| AfricanAmerican-vs-Asian |
9.724000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.578400E-04 |
| Normal-vs-Female |
2.113500E-02 |
| Male-vs-Female |
4.262400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.162300E-04 |
| Normal-vs-Extreme_Weight |
2.182500E-04 |
| Normal-vs-Obese |
2.924200E-02 |
| Normal-vs-Extreme_Obese |
2.615300E-04 |
| Normal_Weight-vs-Extreme_Weight |
9.772400E-01 |
| Normal_Weight-vs-Obese |
2.252400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.155800E-01 |
| Extreme_Weight-vs-Obese |
1.754410E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.780200E-01 |
| Obese-vs-Extreme_Obese |
1.403610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.577000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.625730E-02 |
| Normal-vs-Age(61-80Yrs) |
4.01279999999726E-05 |
| Normal-vs-Age(81-100Yrs) |
1.056990E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.248600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.146400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.117900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.552300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.381190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.949000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.237500E-03 |
| Normal-VS-Type2 PRCC |
9.59960000379567E-08 |
| Normal-VS-KIRP CIMP |
4.439800E-01 |
| Normal-VS-Unclassified PRCC |
1.181650E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.413100E-04 |
| Type1 PRCC-VS-KIRP CIMP |
9.620800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.880000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.436600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.720900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
9.144600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.83722000000053E-05 |
| Normal-vs-N1 |
3.844600E-01 |
| Normal-vs-N2 |
2.891700E-02 |
| N0-vs-N1 |
8.416000E-02 |
| N0-vs-N2 |
9.979800E-01 |
| N1-vs-N2 |
4.427800E-01 |
|
|
